Acinetobacter baumannii antibiotic resistance mechanisms
Data
2021Language
en
Soggetto
Abstract
Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to public health by causing severe and invasive (mostly nosocomial) infections linked with high mortality rates. During the last years, this pathogen displayed multidrug resistance (MDR), mainly due to extensive antibiotic abuse and poor stewardship. MDR isolates are associated with medical history of long hospitalization stays, presence of catheters, and mechanical ventilation, while immun-ocompromised and severely ill hosts predispose to invasive infections. Next-generation sequencing techniques have revolutionized diagnosis of severe A. baumannii infections, contributing to timely diagnosis and personalized therapeutic regimens according to the identification of the respective resistance genes. The aim of this review is to describe in detail all current knowledge on the genetic background of A. baumannii resistance mechanisms in humans as regards beta-lactams (penicillins, cephalosporins, carbapenems, monobactams, and beta-lactamase inhibitors), aminoglycosides, tet-racyclines, fluoroquinolones, macrolides, lincosamides, streptogramin antibiotics, polymyxins, and others (amphenicols, oxazolidinones, rifamycins, fosfomycin, diaminopyrimidines, sulfonamides, glycopeptide, and lipopeptide antibiotics). Mechanisms of antimicrobial resistance refer mainly to regulation of antibiotic transportation through bacterial membranes, alteration of the antibiotic target site, and enzymatic modifications resulting in antibiotic neutralization. Virulence factors that may affect antibiotic susceptibility profiles and confer drug resistance are also being discussed. Reports from cases of A. baumannii coinfection with SARS-CoV-2 during the COVID-19 pandemic in terms of resistance profiles and MDR genes have been investigated. © 2021 by the authors.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Short communication: Bovine mastitis caused by a multidrug-resistant, mcr-1-positive (colistin-resistant), extended-spectrum β-lactamase–producing Escherichia coli clone on a Greek dairy farm
Filioussis G., Kachrimanidou M., Christodoulopoulos G., Kyritsi M., Hadjichristodoulou C., Adamopoulou M., Tzivara A., Kritas S.K., Grinberg A. (2020)We performed a survey aimed at analyzing milk samples collected from cows with mastitis for the presence of extended-spectrum β-lactamase (ESBL)–producing Escherichia coli. Single-quarter mastitic milk samples obtained ... -
CTX-M-type β-lactamases affect community Escherichia coli treatment, Greece [1]
Pournaras, S.; Ikonomidis, A.; Sofianou, D.; Tsakris, A.; Maniatis, A. N. (2004) -
Cross‐Sectional Survey of Antibiotic Resistance in Extended Spectrum β‐Lactamase‐Producing Enterobacteriaceae Isolated from Pigs in Greece
Tsekouras N., Athanasakopoulou Z., Diezel C., Kostoulas P., Braun S.D., Sofia M., Monecke S., Ehricht R., Chatzopoulos D.C., Gary D., Krähmer D., Spyrou V., Christodoulopoulos G., Billinis C., Papatsiros V.G. (2022)This study aimed to estimate the prevalence of extended‐spectrum β‐lactamase-producing (ESBL) bacteria in swine. Thus, 214 fecal samples were collected from suckling and weaned piglets from 34 farms in Greece (out of an ...